KBC Group NV »

Moonlake Immunot shares owned by KBC Group NV

Quarter-by-quarter ownership of Moonlake Immunot (MLTX) shares owned by KBC Group NV from 13F filings

Historical chart of KBC Group NV investment in Moonlake Immunot

Tip: Access up to 7 years of quarterly data

All positions including Moonlake Immunot held by KBC Group NV consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Moonlake Immunot by KBC Group NV

Quarter filed Position value Share count Share price at filing
2024-03-31 $28k 565 49.56

More positions owned by KBC Group NV

Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Alphabet Cap Stk Cl C (GOOG)
Amazon (AMZN)
Meta Platforms Cl A (META)
Broadcom (AVGO)
Pepsi (PEP)
Qualcomm (QCOM)
Eli Lilly & Co. (LLY)
Applied Materials (AMAT)
Accenture Plc Ireland Shs Class A (ACN)
UnitedHealth (UNH)
Merck & Co (MRK)
Adobe Systems Incorporated (ADBE)

View all positions for KBC Group NV

Top funds holding Moonlake Immunot

BVF
Cormorant Asset Management
FMR
venBio Select Advisor
Citadel Advisors
Adage Capital Partners GP
T. Rowe Price Associates
Holocene Advisors
Federated Investors
T. Rowe Price Investment Management
Alliancebernstein
Westfield Capital Management Company
Polar Capital Holdings
Fred Alger Management
Marshall Wace

View all funds holding Moonlake Immunot